Daniel Dendinger

Daniel Dendinger is an experienced finance professional currently serving as Associate Director of Finance at NeoGenomics Laboratories since April 2023. Prior to this role, Daniel held the position of Senior Manager of Accounting and FP&A at Oncocyte Corporation from July 2021 to April 2023. Daniel's career at NeoGenomics Laboratories began in January 2016, where Daniel held dual roles as FP&A Manager and Accounting Manager until July 2021. Before joining NeoGenomics, Daniel worked at GE Healthcare as an Accounting Manager from February 2012 to December 2015, and at Clarient as a Senior Accountant and Stock Plan Administrator from March 2008 to January 2012, where responsibilities included supervising stock plan administration and presenting financial reports. Daniel's career began as a Staff Accountant at STEC, Inc. from July 2005 to August 2007, where Daniel directed financial reporting for foreign subsidiaries and educated teams on accounting compliance. Daniel Dendinger earned a Bachelor of Science degree in Accounting from California State University, Long Beach, from 2002 to 2005.